Replying to @KaminiWalia
@KaminiWalia A timely reminder that innovation, regulation, and stewardship must advance together. Zaynich's FDA approval marks a defining moment for Indian drug discovery and the fight against antimicrobial resistance. Congratulations to all involved. #AMR
Congratulations to @KaminiWalia @ICMRDELHI @CDSCO for their pivotal role in advancing the research ecosystem that enabled #Zaynich to achieve US FDA approval. This success demonstrates that world-class research from India can deliver life-saving solutions for the world.
Congratulations to @KaminiWalia @ICMRDELHI @sonamvijay26 for their pivotal role in advancing the research ecosystem that enabled #Zaynich to achieve US FDA approval. This success demonstrates that world-class research from India can deliver life-saving solutions for the world.
Congratulations to @KaminiWalia @ICMRDELHI @PMOIndia for their pivotal role in advancing the research ecosystem that enabled #Zaynich to achieve US FDA approval. This success demonstrates that world-class research from India can deliver life-saving solutions for the world
Subscribe to Beyond the Noise pauloffit.substack.com/?r=5b…
Balaji Veeraraghavan retweeted
Replying to @sonamvijay26
@sonamvijay26 presenting the structure and framework of @ICMRDELHI AMR surveillance network.
#ivi
#mottmcdonald #UKaid
Balaji Veeraraghavan retweeted
ICMR AMR team will be sharing Indian experiences from Antimicrobial resistance surveillance network at IVI AMR TRAINING @IVIHeadquarters @seoul @ICMRDELHI
Balaji Veeraraghavan retweeted
Indeed a sad day for the country as the nation mourns the death of #EconomistPrimeMinister. Someone who led by example, honest, humble and so professionally accomplished. Yet mortified by those who don't understand grace and humility.
History indeed will be kinder to him 🙏🏻
Why Do Urinary Tract Infections (UTI) Recur? asm.org/Articles/2024/May/Wh…
Balaji Veeraraghavan retweeted
Our latest study is live on bioRxiv 🥳🎊
In this study, @PulseNet_Africa leverages Nanopore sequencing to:
🧬Characterise Vibrio cholerae lineages
⚠️Map antimicrobial resistance
🌟Strengthen genomic capacity in Africa
Read here: shorturl.at/tpUQO #Cholera #AMR #Genomics
Balaji Veeraraghavan retweeted
Congratulations on the @ndtv award, @GKangInd, and well said! More research on our own problems can help develop affordable, innovative solutions for the world! ndtv.com/india-news/gangande… @cmcvelloreoff @ICMRDELHI @DBTIndia
Balaji Veeraraghavan retweeted
We need to create systems to reduce misuse and encourage rational use of new drugs. Improper and irresponsible use will compromise the longevity of these new drugs
#AMR @CDSCO_INDIA_INF
@ICMRDELHI @MoHFW_INDIA
www-bbc-co-uk.cdn.ampproject…
Balaji Veeraraghavan retweeted
Chief minister @OmarAbdullah releasing the antibiotics policy is a great beginning for #AMR containment efforts in the State. Kudos to #AMS team @DirectorSkims for commitment and splendid work!!
Balaji Veeraraghavan retweeted
An all-in-one bioinformatics pipeline for analysing pneumococcal genomes.
Please feel free to let us know your users experience by emailing us :)
Streamline analysing pneumococcal genomes at scale ?
Try out the GPS pipeline to do everything for you in one go!
QC ✅
In silico serotype ✅
GPSC✅
MLST✅
Susceptibilities to 20 antibiotics ✅
De novo assemblies ✅
#pneumococci #genomic #surveillance
biorxiv.org/content/10.1101/…
New Publication Alert!
"Exploring the necessity of molecular detection for Streptococcus dysgalactiae subsp. equisimilis: An often misdiagnosed yet emerging pathogen"
Read More: doi.org/10.1016/j.ijmmb.2024…
New publication alert:
"In vitro Activity of Zidebactam/Cefepime (WCK 5222), a β-Lactam Enhancer/β-Lactam Combo Against Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates"
WCK 5222 potent against MDR pathogens.
Read More: doi.org/10.1016/j.diagmicrob…
Balaji Veeraraghavan retweeted
Doing good science is 90% finding a science buddy to constantly talk to about the project.
Infographic: The World Health Organization's 2024 bacterial pathogens List - politico.eu/article/most-dea…


















